CENBF (CEN Biotech) Total Payout Yield %: 0.00 (As of Jul. 12, 2026)


What is CEN Biotech Total Payout Yield %?

CEN Biotech CENBF Total Payout Yield % is 0.00 as of Jul. 12, 2026.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

CEN Biotech's current Total Payout Yield % is 0.00%.

CEN Biotech Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

CEN Biotech Total Payout Yield % Related Terms

CEN Biotech Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for CEN Biotech's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEN Biotech Total Payout Yield % Chart

CEN Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Payout Yield %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

CEN Biotech Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CENBF vs INLB, NEPT, SGBI: Total Payout Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CEN Biotech's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CEN Biotech Total Payout Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CEN Biotech's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where CEN Biotech's Total Payout Yield % falls into.


CEN Biotech Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

CEN Biotech's Total Payout Yield % for the fiscal year that ended in Dec. 2022 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0 + 0) / 2.6608551
=0.00%

CEN Biotech's annualized Total Payout Yield % for the quarter that ended in Mar. 2023 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 1.30512
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of 0.00 mean?
CEN Biotech (CENBF) has a Total Payout Yield % of 0.00 as of Jul. 12, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on CEN Biotech and its competitors.
Is CEN Biotech's Total Payout Yield % too high?
CEN Biotech's current Total Payout Yield % is 0.00.
How does CEN Biotech's Total Payout Yield % compare to INLB and NEPT?
CEN Biotech's Total Payout Yield % of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Drug Manufacturers company?
A good Total Payout Yield % depends on the Drug Manufacturers industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on CEN Biotech and its competitors. CEN Biotech's current Total Payout Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEN Biotech stock overvalued right now?
CEN Biotech (CENBF) has a current Total Payout Yield % of 0.00. The current Total Payout Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For CEN Biotech (CENBF), the current Total Payout Yield % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEN Biotech Business Description

Address 3295 Quality Way, Suite 300, Windsor, ON, CAN, N8T 3R9
CEN Biotech Inc is an early-stage Canadian biopharmaceutical company. The Company grows, sells, and delivers pharmaceutical-grade medical marijuana to patients.